File HB4469 ("Illinois partners to lower generic drug prices") is before the Illinois Legislature and has not been decided. Latest step (March 27, 2026): Rule 19(a) / Re-referred to Rules Committee.
Illinois file HB4469, before the Illinois Legislature. Still to be decided as of 2026-03-27.
Lower costs on common generic medications Illinois residents and state health programs may pay less for frequently used generic drugs if DHS successfully negotiates lower prices with manufacturers starting January 1, 2029.
Increased drug competition and supply stability Partnerships designed to boost generic drug manufacturing capacity could reduce shortages and improve availability across private insurers, hospitals, and pharmacy benefit managers statewide.
Success depends on appropriations and manufacturer buy-in The bill requires future state funding to operate and relies on voluntary participation from FDA-registered drug companies; if manufacturers decline or funding is insufficient, the price-reduction targets may not materialize.
Creates the Illinois Affordable Drug Manufacturing Act. Provides that the Department of Human Services shall enter into partnerships with drug companies or manufactures to: (i) increase competition, lower prices, and address shortages in the market for generic prescription drugs; (ii) reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers; and (iii) increase patient access to affordable drugs. Provides that such partnerships shall be made with the intent to ensure the wide availability of generic prescription drugs to public and private purchasers, providers and suppliers, and pharmacies as appropriate. Requires that such drugs must be produced or distributed by a drug company or generic drug manufacturer that is registered with the United States Food and Drug Administration. Sets forth price setting criteria and a list of the most common generic prescription drugs that are to be produced and distributed through the partnerships. Requires the Department to consult with other State agencies, licensed health care service plans, health insurers, hospitals, and pharmacy benefit managers in maintaining the list of generic prescription drugs. Co
Read the official record for HB4469
See everything up for a vote · This week in Illinois · See what we have filed with the clerk